A new approach to treat rosacea and other inflammatory skin conditions could be on the horizon, according to a University of ...

Selinexor with ruxolitinib demonstrated encouraging efficacy with a manageable safety profile in patients with myelofibrosis ...

Brittany Lancellotti, DVM, DACVD, talks about available treatment options for flea allergies, environmental allergies, and more ...

It can take twice as long for people to receive an ALS diagnosis if they are seen in a general neurology clinic compared to a specialist clinic, ...

An initial clinical trial, published in August in the American Journal of Psychiatry, demonstrated a significant reduction in symptom severity among participants with MDD. Notably, 80% of patients ...

An estimated one-quarter to one-third of people with schizophrenia have symptoms that don’t improve with traditional ...

The findings add to evidence that the company’s drug, obicetrapib, could change the narrative surrounding a once-abandoned ...

Researchers found that transmission of rotavirus vaccine strains in a neonatal intensive care unit (NICU) is rare and without clinical consequences, strongly suggesting that giving the rotavirus ...

The trial was investigating the use of vagus nerve stimulation (VNS) for inflammatory bowel disease (IBD), an autoimmune ...

CervoMed’s ex-Vertex drug has failed to reduce the severity of patients’ dementia in a phase 2 trial, halting plans for a ...

Researchers at the Foundation have uncovered new insights into the complex link between dopamine and rest tremor in Parkinson ...

A cohort study evaluated how polygenic risk scores (PRS) and polysocial scores (PSS), which include social determinants of health (SDOH) and lifestyle-psychological factors, correlate to risk of ...